Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION

Last updated on 2025-05-20 History
Report ID 257276
Drug Identification Number 02327813
Brand name GALLIUM (GA67) CITRATE INJECTION
Common or Proper name Gallium (Ga 67) Citrate injection
Company Name CURIUM CANADA INC
Market Status MARKETED
Active Ingredient(s) GALLIUM CITRATE GA 67
Strength(s) 74MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 ml
ATC code V09HX
ATC description
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2025-05-18
Actual start date
Estimated end date 2025-05-19
Actual end date 2025-05-19
Shortage status Resolved
Updated date 2025-05-20
Company comments Delivery impact resulting from change to the production and distribution of Ultra-TechnekowTM V4 (Technetium Tc 99m Generator). There is a one time change in the production and distribution of our Sunday, May 18 generator run. As a result, all products that normally would ship on Sunday, May 18 will ship on Monday, May 19. This will be a one-time shift that only impacts generators, gallium and Octreoscan orders on May 18. We apologize for the disruption in service.
Health Canada comments
Tier 3 Status No
Contact Address 2572 BOUL. DANIEL-JOHNSON
LAVAL, QUEBEC
CANADA H7T 2R3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-05-20 French Compare
v4 2025-05-20 English Compare
v3 2025-05-19 English Compare
v2 2025-05-14 French Compare
v1 2025-05-14 English Compare

Showing 1 to 5 of 5